Get startedLog in
    Picture of Plandai Biotechnology logo

    PLPL — Plandai Biotechnology Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    FinancialsHighly SpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Plandai Biotechnology, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

    R2012
    June 30th
    2013
    June 30th
    R2014
    June 30th
    2015
    June 30th
    2016
    June 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K/A10-K/A10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue0.0740.3590.2660.0930.298
    Cost of Revenue
    Gross Profit0.074-0.604-0.629-0.693-0.645
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Total Operating Expenses3.883.0210.88.943.41
    Operating Profit-3.81-2.66-10.5-8.85-3.11
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-3.84-2.97-16-10.1-4.74
    Provision for Income Taxes
    Net Income After Taxes-3.84-2.97-16-10.1-4.74
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-3.78-2.19-15.6-9.58-4.38
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Dilution Adjustment
    Diluted Net Income-3.78-2.19-15.6-9.58-4.38
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.039-0.02-0.086-0.065-0.025
    Dividends per Share